Incidence of Chemotherapy-Induced Nausea and Emesis after Modern Antiemetics: Perception versus Reality

Cancer

Volumn 100, Issue 10, 2004, Pages 2261-2668

  Grunberg, Steven M ^a,i   Deuson, Robert R ^b   Mavros, Panagiotis ^b   Geling, Olga ^b   Hansen, Mogens ^c   Cruciani, Giorgio ^d   Daniele, Bruno ^e   De Pouvourville, Gerard ^f   Rubenstein, Edward B ^g   Daugaard, Gedske ^h  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c HILLERØD HOSPITAL   (Denmark)

^d Ospedale di Lugo   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Rigshospitalet   (Denmark)

ⁱ FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Chemotherapy; Emesis; Nausea; Perception

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE TIME EFFECT RELATION; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NURSE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

EID: 2342616739     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20230     Document Type: Article

References (17)

1. Coates A, Abraham S, Kaye SB, et al. On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19:203-208.
2. Gralla RJ, Itri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981;305:905-909.
3. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med. 1993;329:1790-1796.
4. Kris MG, Gralla RJ, Clark RA, et al. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol. 1985;3: 1379-1384.
5. Italian Group for Antiemetic Research. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Support Care Cancer. 1999;8:229-232.
6. Hesketh PJ, Kris MG, Grunberg SM, et al. A proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997;15:103-109.
7. Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996;7:189-195.
8. Carelle N, Piotto E, Bellanger A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 2002;95:155-163.
9. Hickok JT, Roscoe JA, Morrow GR, et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics. Cancer. 2003;97:2880-2886.
10. Glaus A, Böhme C, Deuson R, et al. Chemotherapy induced nausea and vomiting in routine practice-a European perspective [abstract]. Support Care Cancer. 2002;10:368.
11. De Angelis V, Roila F, Sabbatini R, et al. Cancer chemotherapy-induced delayed emesis: antiemetic prescriptions in clinical practice [abstract]. Proc Am Soc Clin Oncol. 2003;22:739.
12. Rubenstein EB, Litke SE, Jose MA. Chemotherapy-induced nausea and emesis in the 5HT3 era: a national survey of hematologists/oncologists [abstract]. Proc Am Soc Clin Oncol. 2002;21:260b.
13. Newell S, Sanson-Fisher RW, Girgis A, et al. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer. 1998;83:1640-1651.
14. Mertens WC, Higby DJ, Brown D, et al. Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines. J Clin Oncol. 2003;21: 1373-1378.
15. Munch S. A qualitative analysis of physician humanism: women's experiences with hyperemesis gravidarum. J Perinatol. 2000;20:540-547.
16. Navari RM, Reinhardt RR, Gralla RJ, et al. Reduction of cisplatin-induced emesis by a selective neurokinin-1 receptor antagonist. N Engl J Med. 1999;340:190-195.
17. Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy. results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol. 2003;14:1570-1577.